PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pharvaris N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026
$29.77+2.03 (+7.32%)
Close on Oct 19, 2026
Community
Notes and questions about Pharvaris from other investors
No posts about PHVS yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.